MedTrace Logo

Strategies for Hepatitis C Testing and Treatment in Aboriginal Communities That Lead to Elimination

NCT03776760 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2022-04-14

No results posted yet for this study

Summary

A community-based "test and treat" intervention integrating point-of-care HCV RNA testing, non-invasive liver disease assessment and linkage to care will lead to a reduction in HCV prevalence among people attending Aboriginal health services.

Conditions

  • Hepatitis C
  • Hepatitis
  • Liver Diseases
  • Hepatitis, Viral, Human
  • RNA Virus Infections
  • Digestive System Diseases

Interventions

DEVICE

Fingerstick GeneXpert HCV RNA quantitative assay

All participants at risk of HCV infection will receive HCV RNA testing using the GeneXpert finger-stick point-of-care HCV quantitative assay 6 monthly

DRUG

sofosbuvir/velpatesvir

Participants with active HCV infection will be offered treatment with one of two pan-genotypic regimens available in Australia

DRUG

glecaprevir/pibrentasvir

Participants with active HCV infection will be offered treatment with one of two pan-genotypic regimens available in Australia

Sponsors & Collaborators

  • South Australian Health and Medical Research Institute

    collaborator OTHER

  • Flinders University

    collaborator OTHER

  • Kirby Institute

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-05-28
Primary Completion
2022-08-31
Completion
2022-08-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03776760 on ClinicalTrials.gov